222 related articles for article (PubMed ID: 20484913)
41. Interaction of a standardized mistletoe (Viscum album) preparation with antitumor effects of Trastuzumab in vitro.
Weissenstein U; Kunz M; Urech K; Regueiro U; Baumgartner S
BMC Complement Altern Med; 2016 Aug; 16():271. PubMed ID: 27491866
[TBL] [Abstract][Full Text] [Related]
42. Mistletoe viscotoxins increase natural killer cell-mediated cytotoxicity.
Tabiasco J; Pont F; Fournié JJ; Vercellone A
Eur J Biochem; 2002 May; 269(10):2591-600. PubMed ID: 12027898
[TBL] [Abstract][Full Text] [Related]
43. Interleukin-6-mediated cell growth in multiple myeloma--a role for Viscum album extracts?
Hallek M
Onkologie; 2005 Aug; 28(8-9):387. PubMed ID: 16160399
[No Abstract] [Full Text] [Related]
44. Anticarcinogenic and antimetastatic activity of Iscador.
Kuttan G; Menon LG; Antony S; Kuttan R
Anticancer Drugs; 1997 Apr; 8 Suppl 1():S15-6. PubMed ID: 9179361
[TBL] [Abstract][Full Text] [Related]
45. Antitumor activity of the Korean mistletoe lectin is attributed to activation of macrophages and NK cells.
Yoon TJ; Yoo YC; Kang TB; Song SK; Lee KB; Her E; Song KS; Kim JB
Arch Pharm Res; 2003 Oct; 26(10):861-7. PubMed ID: 14609136
[TBL] [Abstract][Full Text] [Related]
46. Paediatric medulloblastoma cells are susceptible to Viscum album (Mistletoe) preparations.
Zuzak TJ; Rist L; Eggenschwiler J; Grotzer MA; Viviani A
Anticancer Res; 2006; 26(5A):3485-92. PubMed ID: 17094471
[TBL] [Abstract][Full Text] [Related]
47. Immune-related and adverse drug reactions to low versus high initial doses of Viscum album L. in cancer patients.
Schad F; Thronicke A; Merkle A; Matthes H; Steele ML
Phytomedicine; 2017 Dec; 36():54-58. PubMed ID: 29157828
[TBL] [Abstract][Full Text] [Related]
48. Absence of tumor growth stimulation in a panel of 26 human tumor cell lines by mistletoe (Viscum album L.) extracts Iscador in vitro.
Kelter G; Fiebig HH
Arzneimittelforschung; 2006 Jun; 56(6A):435-40. PubMed ID: 16927523
[TBL] [Abstract][Full Text] [Related]
49. A Systematic Review and Meta-Analysis on the Survival of Cancer Patients Treated with a Fermented Viscum album L. Extract (Iscador): An Update of Findings.
Ostermann T; Appelbaum S; Poier D; Boehm K; Raak C; Büssing A
Complement Med Res; 2020; 27(4):260-271. PubMed ID: 31927541
[TBL] [Abstract][Full Text] [Related]
50. Sensitization of K562 Leukemia Cells to Doxorubicin by the Viscum album Extract.
Srdic-Rajic T; Tisma-Miletic N; Cavic M; Kanjer K; Savikin K; Galun D; Konic-Ristic A; Zoranovic T
Phytother Res; 2016 Mar; 30(3):485-95. PubMed ID: 26692465
[TBL] [Abstract][Full Text] [Related]
51. Reduction of leukopenia in mice by "viscum album" administration during radiation and chemotherapy.
Kuttan G; Kuttan R
Tumori; 1993 Feb; 79(1):74-6. PubMed ID: 8497925
[TBL] [Abstract][Full Text] [Related]
52. Antioxidant activity of Viscum album ssp. album.
Onay-Uçar E; Karagöz A; Arda N
Fitoterapia; 2006 Dec; 77(7-8):556-60. PubMed ID: 17056203
[TBL] [Abstract][Full Text] [Related]
53. Natural products are the future of anticancer therapy: Preclinical and clinical advancements of Viscum album phytometabolites.
Attar R; Tabassum S; Fayyaz S; Ahmad MS; Nogueira DR; Yaylim I; Timirci-Kahraman O; Kucukhuseyin O; Cacina C; Farooqi AA; Ismail M
Cell Mol Biol (Noisy-le-grand); 2015 Oct; 61(6):62-8. PubMed ID: 26518897
[TBL] [Abstract][Full Text] [Related]
54. Proteomic fingerprinting of mistletoe (Viscum album L.) via combinatorial peptide ligand libraries and mass spectrometry analysis.
Vergara-Barberán M; Lerma-García MJ; Nicoletti M; Simó-Alfonso EF; Herrero-Martínez JM; Fasoli E; Righetti PG
J Proteomics; 2017 Jul; 164():52-58. PubMed ID: 28571969
[TBL] [Abstract][Full Text] [Related]
55. Effects of mistletoe (Viscum album L.) extracts Iscador on cell cycle and survival of tumor cells.
Harmsma M; Ummelen M; Dignef W; Tusenius KJ; Ramaekers FC
Arzneimittelforschung; 2006 Jun; 56(6A):474-82. PubMed ID: 16927529
[TBL] [Abstract][Full Text] [Related]
56. Induction of apoptosis of endothelial cells by Viscum album: a role for anti-tumoral properties of mistletoe lectins.
Duong Van Huyen JP; Bayry J; Delignat S; Gaston AT; Michel O; Bruneval P; Kazatchkine MD; Nicoletti A; Kaveri SV
Mol Med; 2002 Oct; 8(10):600-6. PubMed ID: 12477970
[TBL] [Abstract][Full Text] [Related]
57. Neurophysiological effects of mistletoe (Viscum album L.) on isolated rat intestines.
Radenkovic M; Ivetic V; Popovic M; Mimica-Dukic N; Veljkovic S
Phytother Res; 2006 May; 20(5):374-7. PubMed ID: 16619366
[TBL] [Abstract][Full Text] [Related]
58. Viscum album L. Therapy in Oncology: An Update on Current Evidence.
Thronicke A; Schad F; Debus M; Grabowski J; Soldner G
Complement Med Res; 2022; 29(4):362-368. PubMed ID: 35325897
[TBL] [Abstract][Full Text] [Related]
59. Preclinical investigations with mistletoe (Viscum album L.) extract Iscador.
Maldacker J
Arzneimittelforschung; 2006 Jun; 56(6A):497-507. PubMed ID: 16927531
[TBL] [Abstract][Full Text] [Related]
60. Mistletoe and gemcitabine in patients with advanced cancer: a model for the phase I study of botanicals and botanical-drug interactions in cancer therapy.
Mansky PJ; Grem J; Wallerstedt DB; Monahan BP; Blackman MR
Integr Cancer Ther; 2003 Dec; 2(4):345-52. PubMed ID: 14713326
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
